Decline depth
-36.1%
From rolling 252-day high of $42.21, 97d ago.
Past the 30% Amber threshold.
-36.1%
from rolling 252-day high of $42.21 set 2026-05-11 · 97d ago
Current
$26.98
Decline depth
-36.1%
Decline σ
5.8σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$NAMS landed on the list 2026-03-03, down 27.6% from its 52-week high that day — now down -36.1%.
That's 8.2 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-03-03 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
NAMS qualifies for the Red List on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
5.8σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.47% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about NAMS.
NAMS qualifies for the Red List on decline depth — down -36.1% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.
Cross-confirmation: decline sigma also reads 5.8σ over 20 bars.
Earnings on file: 2026-08-05. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about NAMS
What people ask.
Why is NAMS on Broken Stocks?
NAMS qualifies for the Red List on decline depth. It is down -36.1% from its rolling 252-day high of $42.21, set on 2026-05-11 — 97d ago.
Is NAMS a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. NAMS is down -36.1% from its 52-week high of $42.21, set 97d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is NAMS a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is NAMS trading inside its 52-week range?
At $26.98, NAMS sits 27.4% of the way from its 52-week low ($21.23) to its 52-week high ($42.20). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has NAMS been declining?
The current 36.1% decline accrued over 97d, which annualizes to roughly -135.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does NAMS compare to its sector?
There are 145 other Healthcare tickers on Broken Stocks: 68 Red, 40 Amber, 37 Watch, with 57 showing recovering structural signals. Median sector decline is -35.7% — NAMS's decline is deeper than the sector median.
Does NAMS's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.